These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9925232

  • 21. Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine.
    Sethi A, Chandra D, Puri V, Mallika V.
    Neurol India; 2002 Sep; 50(3):359-63. PubMed ID: 12391470
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
    Handforth A, Treiman DM.
    Epilepsia; 1994 Sep; 35(5):1032-7. PubMed ID: 7925148
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
    Beydoun A, Fischer J, Labar DR, Harden C, Cantrell D, Uthman BM, Sackellares JC, Abou-Khalil B, Ramsay RE, Hayes A, Greiner M, Garofalo E, Pierce M.
    Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Conversion from thrice daily to twice daily administration of gabapentin (GBP) in partial epilepsy: analysis of clinical efficacy and plasma levels.
    Muscas GC, Chiroli S, Luceri F, Mastio MD, Balestrieri F, Arnetoli G.
    Seizure; 2000 Jan; 9(1):47-50. PubMed ID: 10667963
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Clinical studies on gabapentin in Switzerland].
    Shokry A.
    Praxis (Bern 1994); 1996 Jan 23; 85(4):94-8. PubMed ID: 8578060
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group.
    Morrell MJ, McLean MJ, Willmore LJ, Privitera MD, Faught RE, Holmes GL, Magnus L, Bernstein P, Rose-Legatt.
    Seizure; 2000 Jun 23; 9(4):241-8. PubMed ID: 10880282
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Gabapentin--a new antiepileptic agent].
    Nakken KO, Rytter E, Johannessen SI.
    Tidsskr Nor Laegeforen; 1998 Feb 28; 118(6):872-4. PubMed ID: 9543799
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.